Replimune Group, Inc.
NASDAQ:REPL
12.79 (USD) • At close December 26, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Omzet
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Kosten van de omzet
| 2.655 | 2.447 | 4.575 | 4.139 | 1.807 | 0.148 | 0.109 | 0.122 |
| Brutowinst
| -2.655 | -2.447 | -4.575 | -4.139 | -1.807 | -0.148 | -0.109 | -0.122 |
| Brutowinstmarge
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Onderzoek- en ontwikkelingskosten
| 174.963 | 126.527 | 79.545 | 56.754 | 38.761 | 22.173 | 13.516 | 6.936 |
| Algemene en administratieve kosten
| 0 | 0 | 0 | 23.201 | 17.437 | 8.773 | 5.713 | 2.711 |
| Verkoop- en marketingkosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 59.81 | 50.553 | 38.769 | 23.201 | 17.437 | 8.773 | 5.713 | 2.711 |
| Overige kosten
| 0 | -5.676 | -1.059 | -0.665 | -0.016 | 0.451 | -2.056 | 0.626 |
| Bedrijfskosten
| 234.773 | 174.166 | 115.144 | 77.148 | 53.114 | 28.418 | 16.962 | 8.205 |
| Bedrijfsresultaat
| -234.773 | -177.08 | -118.314 | -79.955 | -56.198 | -30.946 | -19.229 | -9.647 |
| Bedrijfsresultaat ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Totaal overige inkomsten en kosten netto
| 19.387 | 3.084 | 0.278 | -0.915 | 3.573 | 0.112 | -0.473 | 1.943 |
| Inkomen voor belasting
| -215.386 | -173.996 | -118.036 | -80.87 | -52.625 | -30.834 | -19.702 | -7.704 |
| Inkomen voor belasting ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Belastingkosten
| 0.408 | 0.288 | 1.164 | 2.395 | 1.903 | 0.451 | -2.056 | 0.125 |
| Nettowinst
| -215.794 | -174.284 | -118.036 | -80.87 | -52.625 | -30.834 | -19.702 | -7.704 |
| Nettowinstmarge
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| WPA (Winst Per Aandeel)
| -3.24 | -2.99 | -2.26 | -1.75 | -1.54 | -1.33 | -0.64 | -0.36 |
| Verwaterde WPA
| -3.24 | -2.99 | -2.26 | -1.75 | -1.54 | -1.33 | -0.64 | -0.25 |
| EBITDA
| -230.198 | -170.303 | -114.408 | -76.478 | -52.597 | -28.27 | -16.853 | -8.083 |
| EBITDA ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |